Two Democratic state attorneys general have launched a multistate lawsuit against the Trump administration, challenging recent changes to the federal childhood vaccine schedule that public health experts warn could reduce immunization rates nationwide. The legal action targets U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and the Centers for Disease Control and Prevention (CDC) over revisions to long-standing vaccine recommendations.
The CDC recently issued an updated immunization schedule that removes universal recommendations for several key vaccines, including COVID-19, rotavirus, influenza, meningococcal disease, hepatitis A, and hepatitis B. Instead, the agency now advises parents to consult healthcare providers under a “shared clinical decision-making” model. Medical organizations argue that eliminating universal guidance could create confusion, weaken public confidence, and ultimately lower childhood vaccination coverage.
California Attorney General Rob Bonta and Arizona’s attorney general announced that 14 states, along with Pennsylvania Governor Josh Shapiro, will file the complaint in federal court in Northern California. According to Bonta, states face unique public health and financial risks if vaccination rates decline. He stated that California may be forced to allocate additional resources to manage outbreaks, treat preventable diseases, and combat vaccine misinformation.
The lawsuit also challenges Secretary Kennedy’s decision to replace members of the CDC’s Advisory Committee on Immunization Practices (ACIP), the expert panel responsible for guiding national vaccine policy. The committee is scheduled to meet in March after its February session was canceled.
HHS spokeswoman Emily Hilliard dismissed the lawsuit as a “publicity stunt,” defending the revised vaccine schedule as a common-sense policy shift.
This multistate legal action mirrors a separate case filed by the American Academy of Pediatrics and other healthcare groups, currently pending before a federal judge in Massachusetts. Participating states reportedly include Connecticut, Michigan, New Jersey, and Wisconsin, signaling growing political and legal opposition to the administration’s vaccine policy changes.


U.S. Blocks Venezuela From Funding Nicolas Maduro’s Legal Defense in New York Drug Trafficking Case
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Trump Seeks Global Coalition to Reopen Strait of Hormuz Amid U.S.-Israel-Iran Conflict
U.S. Oil Executives Warn Trump Administration of Worsening Energy Crisis Amid Strait of Hormuz Disruptions
Trump Administration Pressures Allies to Designate IRGC and Hezbollah as Terror Groups
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Stellantis Shareholder Fraud Lawsuit Dismissed by U.S. Judge
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Russia Launches Massive Missile and Drone Strike on Ukraine, Killing Six
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
California Court Rejects xAI Bid to Block AI Data Transparency Law
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Supreme Court Backs GOP Lawmaker in New York Redistricting Fight Ahead of Midterms
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
California Seeks Court Order to Halt Amazon’s Alleged Price Inflation Practices 



